These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 15246280
1. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin. Bell E, Shamim M, Whitbeck JC, Sfyroera G, Lambris JD, Isaacs SN. Virology; 2004 Aug 01; 325(2):425-31. PubMed ID: 15246280 [Abstract] [Full Text] [Related]
2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Galmiche MC, Goenaga J, Wittek R, Rindisbacher L. Virology; 1999 Feb 01; 254(1):71-80. PubMed ID: 9927575 [Abstract] [Full Text] [Related]
3. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE. J Virol; 2008 Apr 01; 82(7):3517-29. PubMed ID: 18199639 [Abstract] [Full Text] [Related]
4. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Hirao L, Isaacs SN, Moss B, Eisenberg RJ, Cohen GH. J Virol; 2005 May 01; 79(10):6260-71. PubMed ID: 15858010 [Abstract] [Full Text] [Related]
5. Antibody neutralization of the extracellular enveloped form of vaccinia virus. Law M, Smith GL. Virology; 2001 Feb 01; 280(1):132-42. PubMed ID: 11162827 [Abstract] [Full Text] [Related]
6. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity. He Y, Manischewitz J, Meseda CA, Merchlinsky M, Vassell RA, Sirota L, Berkower I, Golding H, Weiss CD. J Infect Dis; 2007 Oct 01; 196(7):1026-32. PubMed ID: 17763325 [Abstract] [Full Text] [Related]
7. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Engelstad M, Smith GL. Virology; 1993 Jun 01; 194(2):627-37. PubMed ID: 8503178 [Abstract] [Full Text] [Related]
9. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees. Viner KM, Isaacs SN. Microbes Infect; 2005 Apr 15; 7(4):579-83. PubMed ID: 15848274 [Abstract] [Full Text] [Related]
10. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Jones-Trower A, Garcia A, Meseda CA, He Y, Weiss C, Kumar A, Weir JP, Merchlinsky M. Virology; 2005 Dec 05; 343(1):128-40. PubMed ID: 16165184 [Abstract] [Full Text] [Related]
11. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response. Stern RJ, Thompson JP, Moyer RW. Virology; 1997 Jun 23; 233(1):118-29. PubMed ID: 9201221 [Abstract] [Full Text] [Related]
12. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH. J Virol; 2008 Jul 23; 82(14):6829-37. PubMed ID: 18448519 [Abstract] [Full Text] [Related]
13. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. Herrera E, Lorenzo MM, Blasco R, Isaacs SN. J Virol; 1998 Jan 23; 72(1):294-302. PubMed ID: 9420227 [Abstract] [Full Text] [Related]
14. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD. Virology; 2011 Oct 25; 419(2):97-106. PubMed ID: 21885079 [Abstract] [Full Text] [Related]
15. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail. Lorenzo MM, Herrera E, Blasco R, Isaacs SN. Virology; 1998 Dec 20; 252(2):450-7. PubMed ID: 9878625 [Abstract] [Full Text] [Related]
16. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection. Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A. J Virol; 2005 Sep 20; 79(18):11873-91. PubMed ID: 16140764 [Abstract] [Full Text] [Related]
17. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination. Mathew EC, Sanderson CM, Hollinshead R, Hollinshead M, Grimley R, Smith GL. Virology; 1999 Dec 05; 265(1):131-46. PubMed ID: 10603324 [Abstract] [Full Text] [Related]
18. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Fang M, Cheng H, Dai Z, Bu Z, Sigal LJ. Virology; 2006 Feb 05; 345(1):231-43. PubMed ID: 16256161 [Abstract] [Full Text] [Related]
19. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. Law M, Pütz MM, Smith GL. J Gen Virol; 2005 Apr 05; 86(Pt 4):991-1000. PubMed ID: 15784892 [Abstract] [Full Text] [Related]
20. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. Mathew E, Sanderson CM, Hollinshead M, Smith GL. J Virol; 1998 Mar 05; 72(3):2429-38. PubMed ID: 9499104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]